glp 1 agonist news Scientists rethink GLP-1 delivery to improve dosing, tolerability, and adherence GLP-1 drugs promise wider health

PMID 3528148

Weight Loss In both trials, a marked dose-dependent WL was observed

They fight inflammation, protect cells from damage, provide benefits to blood vessels, and reduce protein excretion in urine [27]

If retatrutide reduces major cardiovascular events (like semaglutide did in SELECT), the heart rate increase will be viewed as a pharmacologically interesting but clinically irrelevant side effect

Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta

Injectables, such as retatrutide, CagriSema (cagrilintide and semaglutide), and MariTide (maridebart cafraglutide), are in more advanced clinical trials